News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
757,863 Results
Type
Article (48715)
Company Profile (235)
Press Release (708899)
Multimedia
Podcasts (151)
Webinars (24)
Section
Business (240546)
Career Advice (2263)
Deals (36675)
Drug Delivery (151)
Drug Development (83362)
Employer Resources (178)
FDA (16782)
Job Trends (15415)
News (355595)
Policy (33519)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (2)
2027 Biotech Bay Standard (3)
2027 Biotech Beach Elite (2)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (3)
2027 Genetown Standard (5)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (6)
Academia (2655)
Accelerated approval (58)
ADA (48)
Adcomms (35)
Allergies (198)
Alliances (51256)
ALS (237)
Alzheimer's disease (1914)
Antibody-drug conjugate (ADC) (557)
Approvals (17232)
Artificial intelligence (783)
ASCO (333)
Autoimmune disease (363)
Automation (65)
Bankruptcy (375)
Best Places to Work (11740)
BIO (78)
BIOSECURE Act (21)
Biosimilars (243)
Biotechnology (161)
Bladder cancer (209)
Brain cancer (78)
Breast cancer (820)
Cancer (6537)
Cardiovascular disease (537)
Career advice (1915)
Career pathing (48)
CAR-T (381)
CDC (60)
Celiac Disease (3)
Cell therapy (1037)
Cervical cancer (56)
Clinical research (73005)
Collaboration (2367)
Commercialization (1)
Company closure (7)
Compensation (1562)
Complete response letters (104)
COVID-19 (2813)
CRISPR (127)
C-suite (1323)
Cystic fibrosis (162)
Data (8894)
Decentralized trials (3)
Denatured (46)
Depression (190)
Dermatology (104)
Diabetes (686)
Diagnostics (7140)
Digital health (65)
Diversity (13)
Diversity, equity & inclusion (46)
Drug discovery (393)
Drug pricing (214)
Drug shortages (31)
Duchenne muscular dystrophy (323)
Earnings (93251)
Editorial (73)
Employer branding (21)
Employer resources (162)
Events (124956)
Executive appointments (1177)
FDA (20936)
Fibrodysplasia Ossificans Progressiva (10)
Friedreich's ataxia (22)
Frontotemporal dementia (37)
Funding (1948)
Gene editing (273)
Generative AI (69)
Gene therapy (825)
GLP-1 (1152)
Government (4835)
Grass and pollen (6)
Guidances (422)
Healthcare (19325)
Hematology (195)
HIV (91)
Huntington's disease (70)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (117)
Immunology and inflammation (341)
Immuno-oncology (119)
Indications (226)
Infectious disease (3195)
Inflammatory bowel disease (235)
Inflation Reduction Act (14)
Influenza (148)
Intellectual property (328)
Interviews (366)
IPO (17039)
IRA (52)
Job creations (3956)
Job search strategy (1601)
JPM (68)
Kidney cancer (22)
Labor market (113)
Layoffs (616)
Leadership (49)
Legal (8181)
Liver cancer (104)
Longevity (37)
Lung cancer (857)
Lymphoma (489)
Machine learning (68)
Management (64)
Manufacturing (1221)
Marketing (7)
MASH (220)
Medical affairs (1)
Medical device (14076)
Medtech (14256)
Mergers & acquisitions (20963)
Metabolic disorders (1739)
mRNA (251)
Multiple sclerosis (208)
NASH (19)
Neurodegenerative disease (502)
Neuropsychiatric disorders (117)
Neuroscience (3642)
Neurotech (1)
NextGen: Class of 2026 (6700)
Non-profit (4590)
Now hiring (84)
Obesity (805)
Opinion (347)
Ovarian cancer (243)
Pain (279)
Pancreatic cancer (367)
Parkinson's disease (407)
Partnered (37)
Patents (661)
Patient recruitment (809)
Peanut (68)
People (61806)
Pharmaceutical (49)
Pharmacy benefit managers (33)
Phase 1 (22870)
Phase 2 (32198)
Phase 3 (23819)
Pipeline (10238)
Policy (357)
Postmarket research (2596)
Preclinical (9717)
Press Release (72)
Prostate cancer (342)
Psychedelics (66)
Radiopharmaceuticals (357)
Rare diseases (1276)
Real estate (6394)
Recruiting (74)
Regulatory (26569)
Reports (57)
Research institute (2489)
Resumes & cover letters (381)
Rett syndrome (47)
RNA editing (27)
RSV (92)
Schizophrenia (189)
Series A (340)
Series B (248)
Service/supplier (8)
Sickle cell disease (131)
Special edition (30)
Spinal muscular atrophy (172)
Sponsored (49)
Startups (3922)
State (2)
Stomach cancer (19)
Supply chain (139)
Tariffs (92)
The Weekly (102)
Vaccines (1206)
Venture capital (140)
Weight loss (519)
Women's health (139)
Worklife (23)
Date
Today (134)
Last 7 days (472)
Last 30 days (2019)
Last 365 days (31347)
2026 (17405)
2025 (31029)
2024 (35928)
2023 (40727)
2022 (51925)
2021 (56409)
2020 (54741)
2019 (47187)
2018 (35623)
2017 (33211)
2016 (32648)
2015 (38522)
2014 (33888)
2013 (29014)
2012 (29513)
2011 (30184)
2010 (28234)
Location
Africa (826)
Alabama (96)
Alaska (7)
Arizona (370)
Arkansas (15)
Asia (42761)
Australia (7074)
California (14347)
Canada (4037)
China (1619)
Colorado (610)
Connecticut (623)
Delaware (439)
Europe (92578)
Florida (2157)
Georgia (455)
Hawaii (3)
Idaho (63)
Illinois (1191)
India (103)
Indiana (645)
Iowa (25)
Japan (615)
Kansas (139)
Kentucky (54)
Louisiana (58)
Maine (78)
Maryland (1698)
Massachusetts (10345)
Michigan (379)
Minnesota (778)
Mississippi (6)
Missouri (153)
Montana (36)
Nebraska (31)
Nevada (152)
New Hampshire (85)
New Jersey (3775)
New Mexico (31)
New York (3784)
North Carolina (1824)
North Dakota (10)
Northern California (7264)
Ohio (424)
Oklahoma (26)
Oregon (40)
Pennsylvania (2834)
Puerto Rico (31)
Rhode Island (52)
South America (1208)
South Carolina (89)
South Dakota (2)
Southern California (5677)
Tennessee (233)
Texas (2300)
United States (50670)
Utah (430)
Vermont (2)
Virginia (347)
Washington D.C. (82)
Washington State (1156)
West Virginia (4)
Wisconsin (136)
Wyoming (2)
757,863 Results for "shanghai henlius biotech inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Alligator Bioscience Comments on Henlius Update on Global Phase 3 Trial with HLX22
June 8, 2026
·
2 min read
Press Releases
Organon Canada and Henlius Expand Access to Denosumab Treatments With Launch of BILDYOS® (denosumab injection) and TUZEMTY® (denosumab injection), Biosimilars to PROLIA and XGEVA
June 23, 2026
·
5 min read
Press Releases
Alligator Bioscience Comments on Henlius Update on Long-Term Follow-Up Data for HLX22
May 22, 2026
·
2 min read
Press Releases
Alligator Bioscience Announces Initiation of HLX22 Phase 2 Trial in Breast Cancer by Shanghai Henlius Biotech, Inc.
April 23, 2025
·
1 min read
Press Releases
Alligator Bioscience Comments on Henlius Presentation of HLX49 Preclinical Data at AACR 2026
April 23, 2026
·
2 min read
Press Releases
European Commission (EC) Approves Henlius and Organon’s POHERDY® (pertuzumab), the First Approved Biosimilar to PERJETA (pertuzumab) in Europe
April 29, 2026
·
8 min read
Editorial
Biotech’s China problem: An issue of national security or economic value for the US?
Congressional letters sent to the CEOs of Eli Lilly, Pfizer, Merck, BMS and AbbVie this week voicing concerns about the pharmas’ clinical trials in China highlight an ongoing discrepancy in how government and industry think about the rise of the Asian country’s biotech industry.
July 2, 2026
·
6 min read
·
Jef Akst
Press Releases
The Case for Re-Evaluating a Channel Biotech Marketing Wrote Off
By Chris Gadek, AdQuick. Topic: biotech industry trends and career guidance for marketers.
July 8, 2026
·
1 min read
IPO
Hair loss biotech Veradermics, up 656% since its IPO, credits the obesity boom
After debuting on the public markets with $256.3 million and raking in an additional
$472 million
, Veradermics has emerged as one of biotech’s biggest post-IPO standouts. CEO Reid Waldman credits the weight loss craze for establishing consumer-driven channels.
July 6, 2026
·
5 min read
·
Gabrielle Masson
China
New biotech group rises to fuel American rockets in China ‘space race’
Members of the American Biotech Innovation Alliance (ABIA) want to build a national biotech strategy—just like China did years ago.
June 10, 2026
·
3 min read
·
Annalee Armstrong
1 of 75,787
Next
